Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study.
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: June 04, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.
Journal: NEJM evidence
Published: January 27, 2026
The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit-Risk, Autonomy, and Maternal-Fetal Interests.
Journal: American journal of perinatology
Published: December 30, 2025
Tumor Necrosis Factor Inhibitor Treatment and Persistence Patterns in the Peripregnancy Period in Patients With Inflammatory Autoimmune Diseases.
Journal: ACR open rheumatology
Published: August 12, 2025
Improving the Pediatric Research Federal Review Process.
Journal: Pediatrics
Published: November 06, 2024
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.
Journal: American journal of perinatology
Published: August 28, 2024
A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.
Journal: Clinical pharmacology and therapeutics
Published: November 14, 2023
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 15, 2023
Strategies to facilitate adolescent access to medicines: Improving regulatory guidance.
Journal: Clinical trials (London, England)
Published: November 07, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents.
Journal: Journal of Crohn's & colitis
Published: September 21, 2022
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations.
Journal: Paediatric drugs
Published: August 16, 2022
The Role of Master Protocols in Pediatric Drug Development.
Journal: Therapeutic innovation & regulatory science
Published: March 18, 2022
Last Updated: 09/26/2026